Patents by Inventor Richard Andrew Blidner

Richard Andrew Blidner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF RNA AMPLIFICATION
    Publication number: 20220177949
    Abstract: The invention relates to methods of RNA amplification, including methods for the reverse transcription of cDNA from RNA using a thermostable reverse transcriptase. In a particular aspect, the methods are capable of linear amplification of an RNA template through multiple cycles of cDNA synthesis.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 9, 2022
    Inventors: Gary J. Latham, Richard Andrew Blidner, Liangjing Chen
  • Methods of RNA amplification
    Patent number: 11236384
    Abstract: The invention relates to methods of RNA amplification, including methods for the reverse transcription of cDNA from RNA using a thermostable reverse transcriptase. In a particular aspect, the methods are capable of linear amplification of an RNA template through multiple cycles of cDNA synthesis.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: February 1, 2022
    Assignee: ASURAGEN, INC.
    Inventors: Gary J. Latham, Richard Andrew Blidner, Liangjing Chen
  • METHODS OF RNA AMPLIFICATION
    Publication number: 20200140923
    Abstract: The invention relates to methods of RNA amplification, including methods for the reverse transcription of cDNA from RNA using a thermostable reverse transcriptase. In a particular aspect, the methods are capable of linear amplification of an RNA template through multiple cycles of cDNA synthesis.
    Type: Application
    Filed: January 16, 2018
    Publication date: May 7, 2020
    Inventors: Gary J. Latham, Richard Andrew Blidner, Liangjing Chen
  • AMPEROMETRIC DETECTION OF LIMULUS AMEBOCYTE LYSATE ACTIVATION BY ENDOTOXIN AND/OR 1-3-BETA-D-GLUCAN
    Publication number: 20150060272
    Abstract: Devices to detect detecting endotoxin (lipopolysaccharide or LPS) and/or 1-3-?-D-glucan (beta glucan or BG) using substrates including electrogenic mediators for amperometric detection are provided herein. Substrates include an amine group as well as one or more substituted organic rings, such as a phenol. Devices include cartridges for detecting LPS or BG simultaneously using dual detection techniques.
    Type: Application
    Filed: November 14, 2014
    Publication date: March 5, 2015
    Inventors: Richard Andrew Blidner, Albert Gutes-Regidor, Ray R. Radtkey